Lista de obras -

A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy

scientific article published on 17 February 2019

Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper

artículo científico publicado en 2022

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

scientific article published on 28 February 2020

Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers

artículo científico publicado en 2019

Diagnosing, managing and preventing anaphylaxis: systematic review

scientific article published on 02 September 2020

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19

artículo científico publicado en 2020

Diagnosis and treatment of radiocontrast media hypersensitivity

scientific article published on 11 December 2019

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

artículo científico publicado en 2018

Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines

artículo científico publicado en 2020

Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria - a systematic review for the EAACI Biologicals Guidelines

artículo científico publicado en 2020

Genetic Variants Associated with T-Cell Mediated Cutaneous Adverse Drug Reactions: A Prisma-Compliant Systematic Review - an EAACI Position Paper

artículo científico publicado en 2020

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis

artículo científico publicado en 2021

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis

artículo científico publicado en 2021

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021

artículo científico publicado en 2021

Non-invasive and minimally-invasive techniques for the diagnosis and management of allergic diseases

artículo científico publicado en 2020

Omega-5-gliadin-specific immunoglobulin E-positive, but wheat-specific immunoglobulin E-negative wheat allergy dependent on augmentation factors—a frequent presentation

artículo científico publicado en 2023

Practice Parameters for Diagnosing and Managing Iodinated Contrast Media Hypersensitivity

artículo científico publicado en 2020

Promising Use Of The New Biologics In The Management Of Drug-Induced Hypersensitivity Reactions: Preliminary Approaches

artículo científico publicado en 2020

Real‐life evaluation of molecular multiplex IgE test methods in the diagnosis of pollen associated food allergy

artículo científico publicado en 2022

Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis

artículo científico publicado en 2020

The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany

artículo científico publicado en 2020

The role of mobile health technologies in allergy care: An EAACI position paper

artículo científico publicado en 2019

Lista de obras de

A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy

Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers

Diagnosing, managing and preventing anaphylaxis: systematic review

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19

Diagnosis and treatment of radiocontrast media hypersensitivity

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines

Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria - a systematic review for the EAACI Biologicals Guidelines

Genetic Variants Associated with T-Cell Mediated Cutaneous Adverse Drug Reactions: A Prisma-Compliant Systematic Review - an EAACI Position Paper

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021

Non-invasive and minimally-invasive techniques for the diagnosis and management of allergic diseases

Omega-5-gliadin-specific immunoglobulin E-positive, but wheat-specific immunoglobulin E-negative wheat allergy dependent on augmentation factors—a frequent presentation

Practice Parameters for Diagnosing and Managing Iodinated Contrast Media Hypersensitivity

Promising Use Of The New Biologics In The Management Of Drug-Induced Hypersensitivity Reactions: Preliminary Approaches

Real‐life evaluation of molecular multiplex IgE test methods in the diagnosis of pollen associated food allergy

Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis

The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany

The role of mobile health technologies in allergy care: An EAACI position paper